Hainan Kangzhe Pharmaceutical Technology

Hainan Kangzhe Pharmaceutical Technology is a key subsidiary of China Medical System Holdings Limited (CMS), a leading platform-based pharmaceutical company in China. The company focuses on the research, development, and commercialization of innovative drugs across various therapeutic areas, including dermatology, ophthalmology, and cardio-cerebrovascular diseases. By leveraging its parent company's extensive sales network and R&D capabilities, Hainan Kangzhe brings global innovative therapies to the Chinese market. Its portfolio includes both self-developed products and licensed-in assets from international partners. The company is strategically located in the Hainan Free Trade Port to utilize favorable regulatory policies for drug registration and clinical trials.